Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Such insights drive pharmacometabolomics, nutritional studies and translational biomarker programmes
Development of GLP-1MK-801 To safely harness the weight-lowering properties of NMDA receptor antagonism, we developed a targeting approach based on the hypothesis that conjugation of MK-801 to a GLP-1 analogue through a chemically cleavable disulfide linker would enhance the therapeutic potential of NMDA receptor antagonism in appetite-regulating brain regions enriched for GLP-1 receptors, while mitigating the adverse effects related to the non-restricted actions of MK-801
Unlock the potential for a more active and vibrant lifestyle
In those cases, a dose adjustment conversation with your healthcare provider is warranted
US$ 24.14
US$ 26.03
US$ 22.32
US$ 23.59
US$ 26.86
